Clinical Trial Update: A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS [Phase 2]

View source ↗

Summary

A multicenter Phase II randomized open-label trial compares relatlimab plus nivolumab versus nivolumab alone in locally advanced cervical cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (nivolumab)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | Status: ACTIVE_NOT_RECRUITING